Mode
Text Size
Log in / Sign up

Central serous chorioretinopathy

4 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for central serous chorioretinopathy

5 trials tracked for central serous chorioretinopathy.

5Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 3 Other / NA 2
  1. Phase 2 The Safety & Efficacy of Intravitreal Aflibercept Injection in Patients With Persistent Central Serous Chorioretinopathy Completed
  2. Phase 2 Eplerenone for Central Serous Chorioretinopathy Completed
  3. Phase 2 Ranibizumab Versus Low-fluence Photodynamic Therapy in the Treatment of Chronic Central Serous Chorioretinopathy Completed
  4. N/A Eplerenone for the Treatment of Central Serous Chorioretinopathy Completed
  5. N/A Comparison of Multifocal Electroretinogram Assessment in Chronic Central Serous Chorioretinopathy (CSC) Between Laser Treatment Group and Photodynamic Therapy Group in Chronic Central Serous Chorioretinopathy Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.